Müller U, Bödeker R H, Gerundt I, Kurz A
Institut für Humangenetik, Justus-Liebig-Universität, Giessen, Germany.
Neurology. 1996 Dec;47(6):1575-7. doi: 10.1212/wnl.47.6.1575.
We investigated the possibility that a polymorphism of alpha 1-antichymotrypsin modifies the risk for Alzheimer's disease (AD). Testing 147 AD patients and 74 controls, we did not find evidence of an association between alpha 1-antichymotrypsin polymorphism and AD and also failed to detect a modifying effect of this polymorphism in patients carrying at least one epsilon 4 allele of apolipoprotein E.